2
Clinical Trials associated with Recombinant Zoster Vaccine (CHO cell) (Genevax) / Not yet recruitingPhase 1 评价重组带状疱疹疫苗(CHO细胞)在40周岁及以上人群使用的安全性和免疫原性的Ⅰ期临床试验
[Translation] Phase I clinical trial to evaluate the safety and immunogenicity of a recombinant herpes zoster vaccine (CHO cells) in people aged 40 years and above
评价重组带状疱疹疫苗在40周岁及以上人群中使用的安全性和免疫原性。
[Translation] To evaluate the safety and immunogenicity of recombinant herpes zoster vaccine in people aged 40 years and above.
/ Not yet recruitingPhase 2 评价重组带状疱疹疫苗(CHO细胞)在40周岁及以上人群接种的安全性和免疫原性的Ⅱ期临床试验
[Translation] Phase II clinical trial to evaluate the safety and immunogenicity of recombinant herpes zoster vaccine (CHO cells) in people aged 40 years and above
本试验旨在40周岁及以上健康人群中评估接种2剂重组带状疱疹疫苗的安全性和免疫原性,并进行免疫程序探索(第0、2月和第0、1月免疫程序)。
[Translation] This trial aims to evaluate the safety and immunogenicity of two doses of recombinant herpes zoster vaccine in healthy people aged 40 years and above, and to explore the immunization schedule (0, 2 months and 0, 1 month immunization schedule).
100 Clinical Results associated with Recombinant Zoster Vaccine (CHO cell) (Genevax)
100 Translational Medicine associated with Recombinant Zoster Vaccine (CHO cell) (Genevax)
100 Patents (Medical) associated with Recombinant Zoster Vaccine (CHO cell) (Genevax)
100 Deals associated with Recombinant Zoster Vaccine (CHO cell) (Genevax)